Log In
Print
BCIQ
Print
Print this Print this
 

LentiGlobin gene therapy (BB305)

  Manage Alerts
Collapse Summary General Information
Company bluebird bio Inc.
DescriptionLentiviral vector encoding the human beta globin gene delivered into a patient's own hematopoietic stem cells in the bone marrow
Molecular Target
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Viral vector: Lentivirus

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today